Jing'an District, Shanghai, China
Versatile PhD with extensive subject knowledge and hands-on experience: • First-author publications on PNAS, Science Advances, etc. Eight years of practical academic research training in biological engineering with interdisciplinary project experience covers environmental science and informatics • Leadership experience at an immunological solutions start-up responsible for technology transfer, patent filing, product segmentation & launching, and R&D finance • R&D Specialties: Preclinical human vaccine target design and development; Heterologous natural product biosynthesis through molecular biology techniques and small-scale process engineering • Fundamental investment research in Pharmaceutical /Biotechnology • Numerous funding awards and publications
• Vitalgen Series A • Undisclosed Biotech Series A+
• Ansun Biopharma Series C ,Apexigen Series C • Angel round: Neutrolis, Mophogene, Anlong • XtalPi晶泰, Apollomics冠科美博, Sinovent信诺维, Yisheng依生生物, Immune-Onc以明, Teon
• HLK Pharmacin Series A Lead • Admera Health [GENEWIZ spin-off] Series B Lead